Although not reported in AML, NOX5-derived ROS have been demonstrated to lead to inactivation of Src homology region 2 domain-containing phosphatase 1—SHP1 (PTPN6) (Table 1), another PTP, in a model of hairy cell leukaemia [91]. This evidence concerns the gene NOX5 and acute myeloid leukemia.